Researchers develop new compound to fight cytomegalovirus
Tuesday, January 10, 2017 - 13:31
in Health & Medicine
A Retro94-based compound may prevent a common and sometimes fatal virus -- human cytomegalovirus (CMV) -- from reproducing and help to protect immunocompromised patients, such as those with HIV, on chemotherapy, with transplants, and infants from the effects of the disease, according to researchers.